American Century Companies’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-391,051
| Closed | -$26.6M | – | 2639 |
|
2022
Q3 | $26.6M | Buy |
391,051
+13,189
| +3% | +$898K | 0.02% | 575 |
|
2022
Q2 | $12.1M | Buy |
377,862
+25,527
| +7% | +$816K | 0.01% | 844 |
|
2022
Q1 | $12.2M | Sell |
352,335
-1,410
| -0.4% | -$48.8K | 0.01% | 849 |
|
2021
Q4 | $10.4M | Buy |
353,745
+11,720
| +3% | +$343K | 0.01% | 872 |
|
2021
Q3 | $8.72M | Sell |
342,025
-331
| -0.1% | -$8.43K | 0.01% | 882 |
|
2021
Q2 | $12M | Buy |
342,356
+134,684
| +65% | +$4.72M | 0.01% | 777 |
|
2021
Q1 | $8.46M | Buy |
207,672
+79,887
| +63% | +$3.26M | 0.01% | 816 |
|
2020
Q4 | $5.53M | Buy |
127,785
+42,459
| +50% | +$1.84M | ﹤0.01% | 864 |
|
2020
Q3 | $4.71M | Sell |
85,326
-9,141
| -10% | -$504K | ﹤0.01% | 811 |
|
2020
Q2 | $5.96M | Sell |
94,467
-6,367
| -6% | -$402K | 0.01% | 752 |
|
2020
Q1 | $5.15M | Sell |
100,834
-5,199
| -5% | -$266K | 0.01% | 721 |
|
2019
Q4 | $8.43M | Buy |
106,033
+40,715
| +62% | +$3.24M | 0.01% | 723 |
|
2019
Q3 | $3.17M | Buy |
65,318
+3,846
| +6% | +$187K | ﹤0.01% | 891 |
|
2019
Q2 | $3.23M | Buy |
61,472
+14,293
| +30% | +$752K | ﹤0.01% | 925 |
|
2019
Q1 | $2.5M | Sell |
47,179
-8,762
| -16% | -$464K | ﹤0.01% | 962 |
|
2018
Q4 | $2.3M | Sell |
55,941
-2,941
| -5% | -$121K | ﹤0.01% | 948 |
|
2018
Q3 | $2.24M | Sell |
58,882
-419
| -0.7% | -$15.9K | ﹤0.01% | 1010 |
|
2018
Q2 | $2.68M | Buy |
+59,301
| New | +$2.68M | ﹤0.01% | 968 |
|